Australia markets closed

Alpine Immune Sciences, Inc. (ALPN)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
64.56-0.06 (-0.09%)
At close: 04:00PM EDT
64.70 +0.14 (+0.21%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
58,876
58,876
30,064
23,443
9,335
Operating expenses
Research development
80,904
80,904
70,243
58,742
27,185
Selling general and administrative
22,222
22,222
17,968
14,560
10,899
Total operating expenses
103,126
103,126
88,211
73,302
38,084
Operating income or loss
-44,250
-44,250
-58,147
-49,859
-28,749
Interest expense
98
98
476
816
775
Total other income/expenses net
415
415
-97
-4
1,333
Income before tax
-32,081
-32,081
-55,432
-50,420
-27,946
Income tax expense
103
103
2,330
-87
-6
Income from continuing operations
-32,184
-32,184
-57,762
-50,333
-27,940
Net income
-32,184
-32,184
-57,762
-50,333
-27,940
Net income available to common shareholders
-32,184
-32,184
-57,762
-50,333
-27,940
Basic EPS
-1.73
-0.64
-1.73
-1.98
-1.34
Diluted EPS
-1.73
-0.64
-1.73
-1.98
-1.34
Basic average shares
33,435
50,000
33,435
25,477
20,826
Diluted average shares
33,435
50,000
33,435
25,477
20,826